ZVTK - Zevotek Announces Analyst Report Recommending Target $0.77 PPS Published By Goldman Small Cap Research
May 30 2019 - 9:29AM
InvestorsHub NewsWire
ZVTK – Zevotek Announces Analyst
Report Recommending Target $0.77 PPS Published By Goldman Small Cap
Research
Las Vegas, NV -- May 30, 2019 --
InvestorsHub NewsWire -- Zevotek, Inc. (USOTC:
ZVTK) (“ZVTK”) today announced that Goldman Small Cap Research
has issued an analyst report recommending a $0.77 PPS. The
company’s most recent trading has been in the $0.30 range. The
report covers ZVTK’s recently
disclosed proprietary, first-to-market software as a service (SaaS)
the company has had in the works for over a year. ZVTK
earlier this month published an online presentation to introduce
its SaaS solution developed by DALOS specifically targeting a $435 million
segment of an overall $85 billion
market.
The company also recently completed
an asset purchase agreement with Blankki Products, Inc. expanding ZVTK's
high tech asset portfolio to encompass a collective $126
billion in market opportunities. The analyst report is
intended to put ZVTK’s value in perspective now that the company
has gone public with its high-tech asset portfolio and business
strategy.
Goldman reports,
“Our 12-month
target price is $0.77 which is based on figures derived by KPMG
regarding median private company
valuations. This
estimate reflects what we believe will be the combined value of the
two Zevotek investee companies next year. This target could rise if
new portfolio companies join the Zevotek
family.”
The full Goldman Small Cap Research Report on
Zevotek (USOTC:
ZVTK)
About the
Company
Zevotek, Inc., seeks investment
opportunities in startups to provide funding, in addition to
strategic business development assistance to include supplier &
vendor management, software development, marketing, management and
research & development. Zevotek will catalyze the growth of
Market Disruptive & Game Changing Business in the IOT, Business
Automation, Data Processing, Business Analytics & Connected
Healthcare sectors.
For further information visit our website
at www.zevotek.io.
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995: Forward-looking
statements in this release with respect to Zevotek, Inc.'s
business, financial condition and results of operations, as well as
matters of timing and the prospective terms of the transaction
described, are subject to risks and uncertainties that could cause
actual results to differ materially from those expressed in the
forward-looking statements, including, but not limited to, certain
delays beyond Zevotek, Inc's control with respect to market
acceptance of their services, whether financing will be available,
the plans for Zevotek, Inc. to provide business development
services as well as certain other risk factors which are and may be
detailed from time to time in Zevotek, Inc.'s
filings.
This press release contains
forward-looking statements. The words or phrases 'may,' 'intends,'
'expects,' 'estimate,' 'indicate,' 'plans,' 'anticipates,' 'could,'
'if,' 'will,' 'should' or similar expressions are intended to
identify 'forward-looking statements.' Actual results could differ
materially from those projected in forward-looking statements as a
result of a number of risks and uncertainties. Statements made
herein are as of the date of this press release and should not be
relied upon as of any subsequent date. Zevotek, Inc. cautions
readers not to place undue reliance on such statements. Unless
otherwise required by applicable law, Zevotek, Inc. does not
undertake, and Zevotek, Inc. specifically disclaims any obligation
to update any forward-looking statements to reflect occurrences,
developments, unanticipated events or circumstances after the date
of such statement.
Zevotek,
Inc.
Jeffrey R.
Carlson
info@zevotek.io
(800)
906-9040
Zevotek (CE) (USOTC:ZVTK)
Historical Stock Chart
From Oct 2024 to Nov 2024
Zevotek (CE) (USOTC:ZVTK)
Historical Stock Chart
From Nov 2023 to Nov 2024